Study examined the protective effects of Oil-Gan fruit extract on diabetic nephropathy in mice, improving kidney function and reducing inflammation and fibrosis. EPE may be a potential treatment for renal dysfunction.
Goldenroot (GP) has potential in treating type 2 diabetes mellitus (T2DM). GP contains 32 components and 326 potential targets related to T2DM, acting through insulin resistance signaling pathways. GP extracts increased glucose uptake and glycogen synthesis, suggesting a potential therapy for T2DM.
Polyphenol-rich blend with metformin may improve management of type 2 diabetes by reducing insulin levels, glucose concentrations, and potential side effects. Further research needed for safety and efficacy.
Scientists synthesized new class of molecules with potential anti-cancer properties, enhancing drug delivery systems. Promising for future cancer treatments.
Researchers synthesized zinc oxide nanoparticles from Pyrus communis fruit extract, which showed potential for anti-diabetic and anti-microbial properties. The nanoparticles were effective against certain bacteria and compared well with standard medications.
Researchers optimized extraction and identified 13 triterpenoid acids in Hippophae rhamnoides L. pomace. TPF showed strong inhibition of α-glucosidase, reducing postprandial glucose levels and improving serum lipid profiles. Pomace may be valuable for functional foods.
Purpurin, a compound from Rubia tinctorum, relieves neuropathic pain in diabetic mice by enhancing bioenergetics and antioxidant effects. Could lead to improved therapy for diabetic patients with peripheral neuropathy.
Compounds from a medicinal plant inhibit cholinesterases and are potential therapies for Alzheimer's disease and diabetes. Ellagic acid derivatives show promising enzyme inhibition. Good for your research!